Skip to content

Clinical trials

Endocrine Gland Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine Gland Neoplasms Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20092
20112
20122
20142
20151
20163
20173
20182
20191
20201
20211
20222
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting5
Terminated3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
M.D. Anderson Cancer Center3
Eli Lilly and Company2
Sumitomo Pharma America, Inc.2
Syndax Pharmaceuticals2
Amgen1
Celgene1
Daniel Bernstein1
Duke University1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine Gland Neoplasms29
Neoplasms17
Lung Neoplasms11
Breast Neoplasms10
Digestive System Neoplasms10
Endocrine System Diseases10
Thyroid Neoplasms10
Head and Neck Neoplasms9
Neoplasms by Site9
Pancreatic Neoplasms8

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.